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ABSTRACT 
 
Purpose: The aim of this study is to assess the validity of a noninvasive lactate 
threshold device (NID) to determine lactate threshold heart rate (LTHR) and 
aerobic threshold heart rate (AeTHR). 
Methods: Twenty-one recreational athletes completed a personalized graded 
exercise test on a treadmill. All participants wore the noninvasive device and 
blood lactate samples were taken at the end of 3-minute stages. Lactate 
threshold heart rate and aerobic threshold heart rate were then calculated using 
four traditional methods and compared against the same heart rate values 
calculated by the device.  
Results: No significant differences were found in lactate threshold heart rate and 
the aerobic threshold heart rate between the noninvasive device and four 
traditional lactate methods.  
Conclusions: This study provides preliminary support for the validity of the NID 
for estimation of LTHR (4mmol), but weaker support for validity at AeTHR 
(2mmol).  
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INTRODUCTION 
 
 
Over the past 50 years the concept and importance of an individual 
athlete’s lactate threshold (LT) has become more common, especially in 
endurance sports. Lactate is a marker of the metabolic strain being experienced 
by the body (Davison, et al., 2000; Jacobs, 1986), and the LT can be used to 
help establish training zones and intensities. For example, when prescribing 
training for an iron distance triathlete (12+ hour event), the LT helps establish the 
aerobic zone which is below LT and where the majority of training will take place. 
Knowing LT also allows the coach to include workouts designed to increase LT 
and therefore increase overall aerobic pace. In addition, multiple testing sessions 
can also be utilized to track an athlete’s progress over time (Billat, 1996).  
Lactate threshold testing is most often performed in a laboratory with 
bench model analyzers, but these models have the downside of cost and 
inconvenience for most athletes, trainers, and coaches. However, portable 
lactate analyzers provide a more cost-efficient and convenient option. Several 
portable models have been tested and found to be valid in their lactate 
measurements, such as the Accutrend Lactate and the Lactate Pro (Baldari, 
Bonavolontà, Emerenziani, Gallotti, Silva & Guidetti, 2009; Tanner, Fuller & 
Ross, 2010) and The Lactate Scout and Lactate Plus (Hart, Drevets, Alford, 
Salacinski & Hunt, 2013; Tanner et al., 2010). However, all of these devices 
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require a sample of blood, such as from a finger stick. Multiple blood samples 
directly from the finger can increase measurement error (Hart et al., 2013). In 
order to conduct a blood sample test, the athlete has to have someone to help 
collect and analyze the sample while they are completing the exercise test. This 
poses an issue for coaches with large teams or athletes that do not live in the 
same location as their coach or near a lab facility. Also, while more economical 
than a bench analyzer, portable blood lactate devices are still expensive, and 
require the recurring purchase of additional testing and calibrating strips. These 
issues have spurred the development of new lactate testing technologies that do 
not require a blood sample, and can be done by an individual athlete anytime 
and anywhere. 
Recently a new device on the market claims to estimate the lactate 
threshold heart rate (LTHR) and aerobic threshold heart rate (AeTHR) via 
measurements of oxygen saturation of the muscle. This noninvasive device is 
marketed to individual athletes as a way to measure and monitor their LT without 
having the need for blood testing or a laboratory facility. The wearable device 
uses near-infrared spectroscopy (NIRS) to measure the oxygen saturation levels 
in the calf muscle during a graded exercise test (GXT), and then applies a 
proprietary algorithm to determine the point of LT. The NIRS device sends light 
into the tissue and it is either absorbed or scattered. The amount that is scattered 
is relative to the oxygen level of the hemoglobin (Hb) and myoglobin (Mb) in the 
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tissue (Grassi et al, 1999). Using laboratory measures, Belardinelli and 
colleagues (1995) described a slow decrease in muscle oxygenation over a lower 
work rate range, followed by a more rapid decrease in the range of the LT and a 
plateau around VO2max. They determined that NIRS can be used as a 
noninvasive method of monitoring skeletal muscle changes in oxygenation during 
incremental exercise. Further, Grassi and colleagues (1999) evaluated whether 
measurements of muscle oxygenated blood by NIRS were associated with the 
onset of blood lactate accumulation. They concluded that there was a high 
correlation (r = 0.95) between the onset of muscle deoxygenation and the lactate 
threshold. 
Despite the support for NIRS for determination of LT, limited testing has 
been performed on novel portable technology that utilizes NIRS, such as the 
NID. The previously cited studies on NIRS were conducted with laboratory 
experiments, and utilized a different testing site (vastus lateralis versus the 
gastrocnemius with the NID). The necessity for a portable lactate-testing device, 
capable of being used individually, is in high-demand within the endurance 
community. If valid, the NID would be able to provide athletes and coaches with 
LT data outside of a laboratory setting, while using a noninvasive method of 
measurement. However, before wide usage of such technology is endorsed for 
LT assessment and training prescription, the validity of the NID must first be 
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determined. Thus, the aim of this study is to assess the validity of a NID for 
lactate (4mmol) and aerobic (2mmol) threshold points. 
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METHODS 
 
 
Participants 
 
 
Participants were recruited from a triathlon club that serves Nacogdoches 
and the surrounding area. An email was sent to the triathlon club offering lactate 
testing to athletes with an explanation of how, when results are applied, LT data 
can enhance their training. Fourteen female (mean ± SD; age: 27-51 yr; height: 
165.0 ± 5.8 cm; mass: 70.2 ± 11.6 kg; BMI: 25.7 ± 4.1 kg/m2; VO2max: 37.8 ± 6.0 
ml/kg/min) and seven male (mean +/- SD; age: 28-53 yr; height: 177.8 ± 7.6 cm; 
mass: 83.5 ± 8.03 kg; BMI: 26.0 ± 1.4 kg/m2; VO2max: 45.9 ± 6.4 ml/kg/min) 
participants were tested. For inclusion criteria, participants from the triathlon club 
were required to be currently training for an endurance event, and were required 
to have had at least 4 weeks of consistent training. Exclusion criteria included 
less than 4 weeks of training, medical issues that would prevent the participant 
from completing the graded exercise test, injuries that would prevent them from 
running on a treadmill, daily carbohydrate intake of less than 40%, and a fatigue 
number higher than and including 8 measured with a 1-item scale developed by 
Van Hooff et al (2007). One participant was eliminated due to holding onto the 
treadmill which affected HR at the specified workload.  
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Instruments 
 
 
BSX Insight 
The BSX Insight (Multisport version, BSX Athletics, Austin, TX) is an 
optical lactate threshold sensor that uses NIRS to measure muscle oxygen 
saturation for subsequent estimation of LT. Specifically, the BSX provides lactate 
threshold heart rate (LTHR) and aerobic threshold heart rate (AeTHR) from an 
individually-prescribed maximum treadmill protocol. The BSX estimates the 
LTHR to occur at 4mmol of blood lactate, while the AeTHR is estimated to occur 
at 2mmol. For accurate measurements, NIRS requires a dark environment, so 
the device is fitted into a compression sleeve that both keeps the light out and 
the device in place on the lower leg.  Details of device placement and protocol 
details are found in the procedures.  
Lactate Plus 
The Lactate Plus (Nova Biomedical Corporation, Waltham, MA) is a 
portable blood lactate analyzer requiring 0.7 microliters of blood and analyzes 
results in 13 seconds. The Lactate Plus has been shown to be suitable as an 
alternative to bench-model analyzers (Hart, Drevets, Alford, Salacinski & Hunt, 
2013; Tanner et al., 2010).  
Indirect Calorimetry 
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Indirect calorimetry is a method of analyzing energy metabolism and is 
estimated from measurements of oxygen (O2) consumption and carbon dioxide 
(CO2) production (Ferrannini, 1988). For the present study, the Vista Mini-CPX 
VO2 chamber type mixing and measurement system (VacuMed, Ventura, CA) 
was utilized to assess breath-by-breath VO2 during the testing protocol. This 
system has been shown to be valid in assessing cardiorespiratory performance 
(Paulucio, Nogueira, Velasques, Ribeiro & Pompeu, 2015). The VO2 and 
respiratory data provided was used to help determined the standard LT for 
comparison to the NID system’s estimation. 
 
Experimental Design and Procedures 
 
 
Before the participants arrived at the Human Performance Lab, they were 
briefed on the testing environment and protocols via an email confirming their 
scheduled test time. Participants were asked to have abstained from exercise for 
at least 24 hours before their scheduled test. Although research has shown that 
diet modifications don’t affect LT (McLellan & Gass, 1989; Yoshida, 1984), 
participants were asked to maintain a normal, well-balanced diet prior to testing 
and record the three prior days of food intake using the MyFitnessPal app. Upon 
arrival, any questions about the protocol and environment were answered. 
Following informed consent, participants completed basic descriptive data. Three 
prior days’ macronutrients were evaluated and the participant was asked to rate 
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their fatigue on a scale of 1 to 10 as described by Van Hooff, Geurts, Kompier, & 
Taris (2007) to screen for exclusion criteria. Height was measured to the nearest 
tenth of a centimeter and weight was measured to the nearest tenth of a 
kilogram.   
NID Preparation 
Next, the following information about the participant was entered into the 
NID app on the iPhone 6: conversational pace (min/mile), 10K pace (min/mile), 
consecutive months of training, training days per week, and running miles per 
week. These values were determined ahead of time by the participant, based on 
recent race and training data. The app then provided a basic outline of the test, 
which the tester and participant reviewed together (Figure 1). Per NID 
instructions, the prescribed protocol was checked for length to confirm that each 
test would last at least 20 minutes to get sufficient data.  
The NID was paired with the iPhone via Bluetooth wireless connection, 
prior to placing it in the compression sleeve, and on the participant’s left calf. 
Appropriate calf sleeve size was determined by measuring the participant’s calf 
at the largest circumference point to the nearest centimeter. The device was then 
positioned on the back of the left calf at the level of the largest circumference of 
the calf. The device was also paired with a heart rate monitor capable of 
transmitting via ANT+ wireless technology [Garmin Heart Rate Monitor 010-
10997-00, Garmin Ltd].   
9 
 
Treadmill Test Protocol  
Participants were familiarized and fitted with a mask for use with the Vista 
Mini-CPX. Measurements of VO2, VCO2, and RER were continuously monitored 
and recorded during the entire duration of the prescribed protocol. After the test, 
VO2max was determined by the Turbofit software, and ventilatory threshold (VT) 
was calculated by the ventilatory equivalent method (Gaskill, Ruby, Walker, 
Sanchez, Serfass & Leon, 2011).  
The test began and followed the paces individually prescribed by the NID 
protocol. At each stage, the app provided a timer, the current pace/speed, 
participant’s heart rate, and muscle oxygenation percent (Figure 2). Every three 
minutes a new stage began, and treadmill speed was manually changed 
according to the speed prescribed on the app until volitional fatigue. Results for 
LTHR, AeTHR and corresponding paces were then immediately available either 
through the app or the product website (Figure 3). 
Blood Lactate Analysis 
Finger prick blood samples were collected before the start of the test, at the 
end of each 3-minute stage, and immediately following the end of the test. Blood 
samples were taken from the tip of the middle or ring finger. The finger site was 
chosen over the earlobe due to the ease of measurement since these sites can be 
used interchangeably (Moran, Prichard, Ansley, & Howatson, 2012). Aliquots of 
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each sample were analyzed by the Lactate Plus (LP), which was calibrated and 
operated in accordance with the manufacturer’s instructions. 
After graphing the lactate values across the stages, two points on the 
curve were determined, the aerobic threshold (AeT) at 2mmol and LT at 4mmol. 
The inflection point where lactate values increased by greater than 1mmol over 
subsequent stages was also noted. If there wasn’t a point at which the graph 
reached 4mmol then the stage before the clear inflection point was considered 
the LT point. The corresponding heart rates for AT and LT were then determined 
at these points.  
For application to the consumer, the present study utilized the 3-minute 
staged protocol individually established by the NID. While some research has 
shown that longer duration stages are better for the assessment of LT (e.g. 
Bishop, Jenkins & MacKinnon, 1998), other research has shown that stage 
durations between 3 and 6 minutes are necessary to obtain precise lactate 
measurements to determine the desired metabolic inflection points especially in 
trained participants (Thoden, 1991). Therefore, since there is not a consensus in 
the research, and 3-minute stages have been shown to be accurate, the present 
study opted to use the individualized 3-minute staged protocol established by the 
NID. 
Statistical Analysis 
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Mean values for VO2, VCO2, lactate, heart rate, and speed were 
calculated along with the heart rates at calculated LT, AeT, and VT. Three 
methods were used to examine the validity of the NID for the two dependent 
variables, LTHR and AeTHR. First, mean differences of LTHR were examined 
between the NID and three standard methods using repeated measures ANOVA. 
The AeTHR determined by the NID and the standard method was analyzed with 
a dependent T-test. Pearson correlations were used to examine linear 
relationships between the NID and three standard methods for LTHR and one 
standard method for AeTHR. Finally, Bland-Altman plots were constructed to 
further examine level of agreement between LTHR and AeTHR measurements 
using estimation from the NID and the standard measures (Altman & Bland, 
1983). 
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RESULTS 
 
 
Mean values ± SD for LTHR, as determined by the NID, and traditional 
estimations 4mmol, >1mmol, VT methods are shown in Figure 4.  
Repeated measures ANOVA showed no significant differences in LTHR 
between the NID and the three traditional methods (Wilks’ Lambda = .798, F 
(3,18) = 1.52, p > .05, ηp2 = .20).  
Mean values ± SD for AeTHR, as determined by the NID, and a traditional 
method of estimation are shown in Figure 5. A dependent T-Test showed no 
significant difference in AeTHR between the NID and the traditional 2mmol 
estimation method (t (20) = .52, p > .05). 
Table 1 shows the Pearson correlation (r) of LTHR from the NID with all 
three traditional estimation methods, which ranged from .77 to .88. A fixed value 
estimation of 4mmol had the highest correlation to the NID estimation for LTHR (r 
= .88). AeTHR, as assessed by the traditional method at 2mmol, was moderately 
correlated to the NID device (r = .66).  
Bland Altman plots showing the mean difference and limits of agreement 
for the NID and all standard methods of LTHR and AeTHR are shown in Figures 
6-9. In general, these plots indicate a small discrepancy (approximately within 10 
bpm difference) between methods for LTHR, with a larger discrepancy with 
AeTHR (approximately 20 bpm difference). LTHR estimated by the traditional 
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4mmol method appeared to have the closest agreement with the NID, especially 
around mean heart rates of 160 to 175 bpm.
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DISCUSSION 
 
 
The purpose of this study was to determine the validity of a NID to 
calculate heart rates at both lactate (4mmol) and aerobic thresholds (2mmol) 
during exercise. In general, the present findings provide preliminary support for 
the validity of the NID during a treadmill GXT to volitional fatigue.  
 
LTHR and AeTHR 
 
 
No significant differences in LTHR means were found between the NID 
and three traditional LTHR estimation methods. The highest correlation with the 
NID was with the 4mmol method and the NID (r = .88), followed by the >1mmol 
increase method (r = .85). The VT estimation of LTHR was correlated at a 
moderate-high level (r = .77). These correlation values indicate initial support for 
the NID’s accuracy at estimating LTHR. 
The Bland Altman plots of LTHR for the four traditional estimation 
methods show most heart rate values falling within the confidence interval. For 
higher LT heart rates, the NID tends to underestimate the HR by a small degree 
(approximately 5-10 bpm).  
In regards to under or over estimation of LT, recent research (Borges & 
Driller, 2016) found that the NID had a tendency to overestimate LT when 
compared with traditional methods but previous research with NIRS (Grassi, 
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Quaresima, Marconi, Ferrari & Cerretelli, 1999) showed an underestimation of 
the heart rate at which LT occurred compared with fixed values. Underestimation 
isn’t necessarily a negative for athletes as it would prevent them from crossing 
their LT in training which could adversely affect their adaptations to training. 
No significant difference was found in AeTHR between the NID and a 
traditional estimation at 2mmol. However, the correlation between the NID and 
traditional method of AeTHR estimation was only moderate (r = .66), indicating 
that the NID did not perform as well estimating AeTHR as it did with LTHR. The 
Bland Altman plot shows most heart rate values falling within the confidence 
interval but more spread out when compared with LT plots. For lower AeT heart 
rates, the NID tends to overestimate the HR by a moderate degree 
(approximately 10-20 bpm). 
Practical Application 
 
 
This study was completed on a sample of participants with a wide range of 
athletic ability (VO2max range = 27.4 to 56.5 ml/kg/min). Compared to the recent 
research (Borges & Driller, 2016), these participants were older, heavier and had 
a higher mean BMI. With the lower values, the present sample represented a 
more recreational group of triathletes than elite. While the present sample might 
be limited in generalizability to elite triathletes our preliminary results support 
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accuracy of the NIRS device for those most likely to purchase and use it without 
the presence of a coach for every test and workout.  
Also, these results support that the device has the capability to estimate 
LTHR with slower athletes which would benefit beginners. Advanced and elite 
athletes could also benefit from the device but need to be aware that it might 
underestimate threshold heart rates if threshold is at a high level due to our 
finding that the NID had a small degree of difference higher LT heart rates.  
Not only does the NID collect data from athletes, it analyzes and presents 
the data in a format that athletes can use immediately. With the standard 
devices, lactate values are obtained but then a person with specialized training is 
required to analyze those points and determine LT, training zones, and training 
paces for an athlete to work within.  
 
Limitations 
 
 
There are several limitations of the present investigation that should be 
noted. First, as a preliminary investigation, a relatively small sample was utilized. 
Our sample of 21 participants is similar to other validation studies with this 
specific device (Borges & Driller, 2016). However, larger samples and further 
research could continue to provide further, more concrete support for the validity 
of this specific device. In addition, the smaller sample did not allow for the testing 
of gender differences for validity of the device in estimating LTHR and AeTHR. 
17 
 
Also, reliability of the device wasn’t examined in the present study, as 
participants were only tested with the same device, one time. Both inter- and 
intra-reliability is an important factor in establishing validity as athletes would use 
this device to track performance over time. 
 
Further Investigation 
 
 
Several additional investigations need to be done with the NIRS device. 
This study used the prescribed 3-minute protocol established by the NID but 
LTHR and AeTHR values need to be compared with those from a more 
traditional LT test with longer stages at lower intensities. Also, participants need 
to complete the present test, and then return within 72 hours to complete a more 
traditional test for reliability.  
 In addition, the NID requires an input of 10K race pace when it creates the 
GXT protocol. The pace at which LTHR was reached was highly correlated (r = 
.90) which means that the proprietary algorithm of the device could be related to 
pace. Tests need to be run where the athlete under- or over-estimates their pace 
to see if the device is still determining the same LTHR.  
  
Conclusions 
 
 
This study provides preliminary support for the validity of the NID for 
estimation of LTHR, but weaker support for validity at AeTHR. Acceptable levels 
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of agreement were found between the two devices when measuring HR at 
lactate threshold, with lesser agreement and greater variability in differences at 
aerobic threshold. However, the preliminary support is encouraging for the 
recreational athlete who could utilize such a device to assess LTHR for training 
purposes in their own environment, without relying on a specialized lab in their 
area.  
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Figure 1. Based on the Assessment questions, the NID  
 
establishes a testing protocol.  
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Figure 2. Metrics shown on the NID app during testing.  
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Figure 3. The results shown in the NID app after testing  
 
completed.  
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Figure 4. The mean ± SD of the lactate threshold heart rate (LTHR), as determined by 
the noninvasive device (NID) and three lactate threshold estimation methods: at 
4mmol, >1mmol, and at ventilatory threshold (VT). 
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Figure 5. The mean ± SD of the aerobic threshold heart rate (AeTHR), as determined 
by the noninvasive device (NID) and an aerobic threshold estimation method (2mmol). 
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Table 1. The Pearson correlation coefficient and associated p-values for the NID device 
compared with traditional estimation procedures. 
 LTHR via NID 
LTHR Traditional Methods r p 
4mmol .88 < .001 
>1mmol increase .85 < .001 
VT .77 .001 
   
 AeTHR via NID 
AeTHR Traditional Method r p 
2mmol .66 .001 
LTHR = lactate threshold heart rate, AeTHR = aerobic threshold heart rate,  
NID = noninvasive device, VT = ventilatory threshold 
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Figure 6. Bland-Altman plot showing levels of agreement of lactate threshold heart  
rate (LTHR) for the noninvasive device (NID) and the traditional 4mmol estimation 
method. 
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Figure 7. Bland-Altman plot showing levels of agreement of lactate threshold heart 
rate (LTHR) for the noninvasive device (NID) and the traditional estimation method at 
>1mmol increase. 
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Figure 8. Bland-Altman plot showing levels of agreement of lactate threshold heart 
rate (LTHR) for the noninvasive device (NID) and the traditional estimation method at 
ventilatory threshold (VT). 
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Figure 9. Bland-Altman plot showing levels of agreement of aerobic threshold heart 
rate (AeTHR) for the noninvasive device (NID) and the traditional 2mmol estimation 
method. 
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